Nonsteroidal Anti-inflammatory Drugs Inhibit Matrix Metalloproteinase-2 via Suppression of the ERK/Sp1-mediated Transcription

This publication has 26 references indexed in Scilit:

• Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN
  Oncogene, 2001
• Expression of Cyclooxygenase–2 Promotes the Release of Matrix Metalloproteinase–2 and –9 in Fetal Rat Hepatocytes
  Hepatology, 2001
• Inactivating Mutation of the Mouse Tissue Inhibitor of Metalloproteinases-2(Timp-2) Gene Alters ProMMP-2 Activation
  Journal of Biological Chemistry, 2000
• Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells
  Oncogene, 2000
• Constitutive Activation of MAP Kinase Kinase (MEK1) Is Critical and Sufficient for the Activation of MMP-2
  Experimental Cell Research, 2000
• Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells
  Oncogene, 1999
• Sp1 Phosphorylation by Erk 2 Stimulates DNA Binding
  Biochemical and Biophysical Research Communications, 1999
• Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic
  Seminars in Cancer Biology, 1996
• Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
  Science, 1994
• Structural biochemistry and activation of matrix metalloproteases
  Current Opinion in Cell Biology, 1993